Pediatric gene therapy is rapidly reshaping what is possible for children born with rare genetic diseases. Join Dr. Rachel Abu Taleb, Medical Director, Medical Affairs at Veristat, for a look at the platforms driving clinical progress, including AAV vectors, lentiviral approaches, and CRISPR-based gene editing. Through examples such as Luxturna, Zolgensma, Casgevy, and Lyfgenia, this...
This expert panel will discuss how digital documentation is reshaping inspection readiness. Panelists will explore the role of electronic batch records, integrated quality systems, and automated workflows in supporting compliance with ALCOA+ principles, while enabling real-time visibility and faster audit response.
Looking for fill-finish manufacturing capacity? This webinar brings together leading CDMOs to showcase their latest sterile filling, lyophilization, and advanced packaging capabilities, along with current facility availability and timelines. Gain valuable insights into quality, regulatory compliance, and manufacturing options to help identify the right partner for your biopharmaceutical development and commercialization needs.
Explore the latest large molecule manufacturing capabilities from leading CDMOs in this informative webinar. Learn about advances in cell line development, fermentation, purification, process optimization, and scale-up, while gaining insight into available capacity, facility locations, and timelines. Whether you're evaluating manufacturing partners or planning future biologics production, this session offers a practical overview to help...
As cell therapies advance toward commercial-scale manufacturing, developers can face increasing pressure to balance performance, scalability, and process flexibility. Flexible modular workflows are emerging as a powerful approach for scalable cell therapy manufacturing, enabling enhanced process control, workflow adaptability, and operational efficiency while maintaining consistency across the manufacturing pipeline. These advantages can be particularly valuable...
Technology transfers can introduce risk and create knowledge gaps at every stage of development, whether it’s moving a process from development to manufacturing, transferring methods between analytical labs, or onboarding a new CDMO partner. This is especially true in the development of antibody-drug conjugates (ADC), where the complexity of conjugation processes, analytical characterization, and specialized...
Moving promising research from the university lab to the CDMO suite requires more than breakthrough science—it requires the right documentation, development strategy, and manufacturing readiness. In this Outsourced Pharma Live discussion, industry experts explore how academic innovators and CDMOs can better align earlier, build stronger technical packages, and create a smoother path to outsourced development...
In this virtual event, leading CDMOs will share how host selection, vector design, and clone screening strategies influence manufacturability from early development through commercialization. Join us to learn what to evaluate early, how to reduce downstream risk, and how to make more informed cell line development decisions.
As biopharmaceutical manufacturing becomes increasingly global, organizations face growing challenges in balancing flexibility, standardization, and scalability. CDMOs must accommodate sponsor-specific requirements, manufacturers must transfer processes across geographically dispersed facilities, and growing programs require equipment platforms that can scale without introducing unnecessary risk or complexity. Successfully navigating these challenges requires more than equipment; it requires a...
Cell & Gene Tech Expo offers a live virtual experience designed to empower industry professionals in sourcing best-fit solutions for their cell and gene therapy manufacturing needs. Through this series of digital sessions, attendees will have the chance to explore the newest equipment and solutions offered by our presenters, aimed at addressing the current challenges...
